Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus and Chronic Obstructive Pulmonary Disease
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40656
Full Text
Open PDFAbstract
Available in full text
Date
October 22, 2018
Authors
Publisher
Wiley